27
Auron Therapeutics, Inc. files Form D
Company raise update · Raising · Offering $42.3M · Sold $27.3M · NEWTON, MA · filed 2025-12-23
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Briggs Duncan Morrison | Director |
| Pini Duncan Orbach | Director |
| Serge Duncan Messerlian | Director |
| Victoria Duncan Richon | Director |
| Alexandra Cantley | Director |
| Anna Duncan French | Director |
| Katharine Yen | Executive Officer, Director |
Signed by Katharine Yen, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.